We’ve acquired Elios Vision, developer of ELIOS™, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser. The acquisition complements our already broad surgical portfolio and demonstrates our commitment to investing in smart, innovative technologies that meet the needs of surgeons and patients. Learn more here: https://bit.ly/4ga243j #SeeBetterLiveBetter #Innovation
Amazing news. Check mate! ♟️
Congratulations! Great technology!! Able to help so many glaucoma patients out there! Exciting times ahead.
Congratulations Fantasic news
Exciting times indeed! Well done team Elios Vision - that’s quite some growth in a couple of years.
Great move. Congratulations to both companies 👏👏👏
Love this
Happy to continue working on the Elios study! Excited about the potential impact this innovative procedure can have on glaucoma treatment and patient outcomes.
Great call! Innovation at its best
Hello, no matter how hard we try to reach you, I cannot reach you to buy a device. Can you please give us the contact information so that we can reach you?
Exciting time to be in ophthalmology, especially glaucoma. #blessedandgrateful #patientsfirst